1. Kaplowitz N. Drug induced liver injury. Clin Infect Dis. 2004;38(Suppl 2):S44–8.[PubMed]
2. Hiraganahalli DB, Chandrasekaran CV, Dethe S, Mundkinajeddu D, Pandre MK, Balachandran J, et al. Hepatoprotective and antioxidant activity of standardized herbal extracts. Phcog Mag. 2012;8:116–23.[PMC free article][PubMed]
3. Valiathan MS. Healing plants. Curr Sci. 1998;75:1122–7.
4. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: Challenges and opportunities. J Ethnobiology Ethnomedicine. 2006;2:32–46.
5. Vyawahare NS, Khandelwal AR, Batra VR, Nikam AP. Herbal anticonvulsants. J Herbal Med Toxicol. 2007;1:9–14.
6. Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, et al. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2007;109:359–63.[PubMed]
7. Ratnasooriya WD, Jayakody JR, Dharmasiri MG. An aqueous extract of trunk bark of Ficus religiosa has anxiolytic activity. Med Sci Res. 1998;26:817–9.
8. Ali M, Qadry JS. Amino acid composition of fruits and seeds of medicinal plants. J Indian Chem Soc. 1987;64:230–31.
9. Bliebtrau JN. New York: Macmillan Company; 1968. The Parable of the Beast; p. 74.
10. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007;100:857–73.[PubMed]
11. Singh D, Rajesh KG. Anticonvulsant effect of Ficus religiosa: Role of serotonergic pathways. J Ethnopharmacol. 2009;123:330–4.[PubMed]
12. Kirana H, Agrawall SS, Srinivasan BP. Aqueous extract of Ficus religiosa linn. Reduces oxidative stress in experimentally induced type 2 diabetic rats. Indian J Exp Biol. 2009;47:822–6.[PubMed]
13. Krishna Mohan G, Pallavi E, Ravi Kumar B, Ramesh M, Venkatesh S. Hepatoprotective activity of Ficus carica Linn. leaf extract against carbon tetrachloride-induced hepatotoxicity in rats. DARU J Pharm Sci. 2007;15:162–6.
14. Harbone JB, Baxter HH. Washington: Taylor and Francis; 1993. Phytochemical Dictionary: A hand Book of Bioactive Compound from plants; p. 237.
15. Trease GE, Evans MC. London: Bailiere Tindall; 1989. Text book of Pharmacognosy; pp. 200–1.
16. Yue J, Peng RX, Yang J, Kong R, Liu J. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin. 2004;25:699–704.[PubMed]
17. Saleem TS, Christina AJ, Chidambaranathan N, Ravi V, Gauthaman K. Hepatoprotective activity of Annona squamosa Linn. on experimental animal model. Int J Appl Res Nat Prod. 2008;1:1–7.
18. Okhawa H, Qohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.[PubMed]
19. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959;82:70–7.[PubMed]
20. Garner P, Holmes A, Ziganahina L. Tuberculosis. Clin Evid. 2004;11:1081–93.[PubMed]
21. Sarich TC, Youssefi M, Zhou T, Adams SP, Wall RA, Wright JM. The role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch Toxicol. 1996;70:835–40.[PubMed]
22. Skakun NP, Shmanko VV. Synergistic effect of Rifampicin on hepatotoxicity of isoniazid. Antibiot Med Biotek. 1985;30:185–9.[PubMed]
23. Ramaiah SK, Apte U, Mehendale HI. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos. 2001;29:1088–95.[PubMed]
24. Yasuda K, Sato A, Chida K. Pulmonary tuberculosis with chemotherapy related liver dysfunction. Kekkadu. 1990;65:407–13.[PubMed]
25. Wu JC, Lee SD, Yeh PF, Chan CY, Wang YJ, Huang YS, et al. Isoniazid-Rifampicin induced hepatitis in hepatitis B carriers. Gastroentrology. 1990;98:502–4.[PubMed]
26. Steele MA, Burk RF, Des Prez RM. Toxic hepatitis with Isoniazid and rifampicin: A meta-analysis. Chest. 1991;99:465–71.[PubMed]
27. Peretti E, Karlaganis G, Lauterburg BH. Acetylating of acetylhydrazine, the toxic metabolite of Isoniazid, in humans: Inhibition by concomitant administration of Isoniazid. J Pharmacol Exp Ther. 1987;243:686–9.[PubMed]
28. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA. 1984;81:1327–31.[PMC free article][PubMed]
29. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993;6:511–8.[PubMed]
30. Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol. 1993;45:1563–9.[PubMed]
31. Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, et al. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol. 1998;11:295–301.[PubMed]
32. Thakare VN, Suralkar AA, Deshpande AD, Naik SR. Stem bark extraction of Ficus benghalensis Linn for anti-inflammatory and analgesic activity in animal models. Indian J Exp Biol. 2010;48:39–45.[PubMed]
33. Angala Parameswari S, Mohamed Saleem TS, Chandrasekar KB, Madhusudhana Chetty C. Protective role of Ficus benghalensis against isoniazid-rifampicin induced oxidative liver injury in rat. Revista Brasileira de Farmacognosia Brazilian Journal of Pharmacognosy. 2012;22(3):604–10.
34. Gutierrez RP, Navarro YG. Antioxidant and hepatoprotective effects of the methanol extract of the leaves of Satureja macrostema. Phcog Mag. 2010;6:125–31.[PMC free article][PubMed]
35. Sharma SK, Arogya SM, Bhaskarmurthy DH, Agarwal A, Velusami CC. Hepatoprotective activity of the Phyllanthus species on tert-butyl hydroperoxide (t-BH)-induced cytotoxicity in HepG2 cells. Phcog Mag. 2011;7:229–33.[PMC free article][PubMed]
36. Lahon K, Das S. Hepatoprotective activity of Ocimum sanctum alcoholic leaf extract against paracetamol-induced liver damage in Albino rats. Phcog Res. 2011;3:13–8.[PMC free article][PubMed]
37. Lima de Medeiros BJ, Costa Kd, Ribeiro JF, Silva JC, Jr, Barbosa WR, Carvalho JT. Liver protective activity of a hydroethanolic extract of Arrabidaea chica (Humb. and Bonpl.) B. Verl. (pariri) Phcog Res. 2011;3:79–84.[PMC free article][PubMed]
Polyherbal formulations available with a wide range of indications like hepatoprotective , appetite and growth promoters, gastrointestinal and hepatic regulator, as treatment for hepatic dysfunction, for hepatic regeneration as well as liver stimulant and tonic. Despite the widespread use, there is a lack of scientific evidence on their efficacy and safety. This study was designed to evaluate the effect of Polyherbal formulation Kamialri on oxidative stress and associated damages in carbon tetrachloride induced toxicity in Chang liver cells. The study is mainly focused on the evaluation of its antioxidant potential, invitro steatosis and intracellular localisation of reduced glutathione by Monochlorobimane(MCB) staining. Carbon tetrachloride induced toxicity in chang liver cells was well manifested by significant decrease in cell viability, enhanced lipid peroxidation leading to tissue damage,decreased SOD, glutathione, glutathione peroxidase and glutathione S- transferase and increased deposition of fatty acid . MTT study revealed that Kamilari has got cytoprotective activity. It has got the excellent free radical scavenging properties which was proven by various antioxidant activities (LP, SOD, GSH, GPX, and GST). Inhibitory effect of Kamilari on fatty acid deposition was proven by invitro steatosis studies which were conducted on palmitic acid treated chang cell line.Based on the above studies it is concluded that Kamilari has cytoprotective and antioxidant activity, and found to be effective in steatosis .
Liver is an important organ that plays an essential role in regulating various physiological processes in the body. It is involved in several vital functions, such as metabolism, secretion and storage. In vitro liver systems represent a better experimental approach to screen potential hepatotoxic compounds. Liver cell lines are characterized by unlimited sub cultivation and cell availability in large number1. The hepatotoxin used was carbon tetrachloride because it has long been known as a model toxicant and has been the focus of many in vitro and in vivo toxicological studies2 . The liver is the major target organ of carbon tetra chloride toxicity owing to its high content of Cytochrome P-4503.
Kamilari is a commercial ayurvedic formulation suggested to be effective in treatment of liver disorder such as jaundice, chronic alcoholism, acute and chronic inflammatory disorders. As per the manufactures information Kamilari consist of Thespesia populinea, Eletteria cardamom, Zingiber officinalis, Glyccyrhiza glabra, Piper longum, Aegle marmelos, Trichosanthes cucumerina, Holostemma adakodein Schulter and Honey.Since large mass of populations used preferable herbal preparation, therefore there is need to be evaluate the proper mechanism underlying the hepatoprotective effect.
Kamilari, a polyherbal formulation of traditional medicinal plants and its in vivo protective effect being reported4 but no valid data is available regarding proper cellular mechanism on carbon tetrachloride toxicity . This study was designed to evaluate the effect of Kamialri on oxidative stress and associated damages in Ccl4 induced toxicity in Chang liver cells. The study is mainly focused on the evaluation of its antioxidant potential, invitro steatosis and intracellular localisation of reduced glutathione by Monochlorobimane(MCB) staining.
2. MATERIALS & METHODS
2.1 Invitro protective effect of Kamilari in Ccl4 treated Chang liver cells
Chemicals and media.
Carbon tetrachloride(0.1%) (Appendix 1), Trypsin (Appendix 1), Foetal bovine serum albumin (Appendix 1), Palmiticacid(20Mm) (Appendix 1), Oil red O (Appendix 1), MTT (3-(4, 5-dimethylthiazolyl)-2, 5-diphenyl-tetrazolium bromide) (Appendix 1),Dimethyl sulfoxide (Appendix1) .
500µl Dimethyl Sulphoxide (DMSO) , Chang liver cell line, Micropipette, Medium –DMEM with 10% FBS pH 7.4, 500µl MTT in PBS, CO2 incubator, UV-Visible spectrophotometer
2.2 Lipid peroxidation6
70% alcohol,1%TBA,400µl acetone,Cell lysate
2.3 Estimation of SOD activity7
50mM phosphate buffer (7.8), 45µM methionine, 5.3mM riboflavin, 84µM NBT, 20 µM potassium cyanide, cell lysate(50µl).